Atsushi Ishii

Fukuoka, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Reply to Letter to the Editor regarding the article "SCN1A gain of function effects in Dravet syndrome: Insights into clinical phenotypes and therapeutic implications".

Reply to Letter to the Editor regarding the article "SCN1A gain of function effects in Dravet syndrome: Insights into clinical phenotypes and therapeutic implications".

Journal: Epilepsia open

Published: August 25, 2025

Lasmiditan ameliorates cortico-hippocampal pathology and improves cognition in aging parkinsonian mice.

Lasmiditan ameliorates cortico-hippocampal pathology and improves cognition in aging parkinsonian mice.

Journal: Experimental neurology

Published: June 15, 2025

Acute E2/P4 loss compromises the biology and function of neurogenic niches during a vulnerable female aging period.

Acute E2/P4 loss compromises the biology and function of neurogenic niches during a vulnerable female aging period.

Journal: bioRxiv : the preprint server for biology

Published: June 04, 2025

Acute E2/P4 loss compromises the biology and function of neurogenic niches during a vulnerable female aging period.

Acute E2/P4 loss compromises the biology and function of neurogenic niches during a vulnerable female aging period.

Journal: Stem cell reports

Published: April 24, 2025

SCN1A gain of function effects in Dravet syndrome: Insights into clinical phenotypes and therapeutic implications.

SCN1A gain of function effects in Dravet syndrome: Insights into clinical phenotypes and therapeutic implications.

Journal: Epilepsia open

Published: April 14, 2025

The 5-HT1F Receptor Agonist Lasmiditan improves Cognition and Ameliorates Associated Cortico-Hippocampal Pathology in Aging Parkinsonian Mice.

The 5-HT1F Receptor Agonist Lasmiditan improves Cognition and Ameliorates Associated Cortico-Hippocampal Pathology in Aging Parkinsonian Mice.

Journal: bioRxiv : the preprint server for biology

Published: March 03, 2025

Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes.

Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes.

Journal: medRxiv : the preprint server for health sciences

Published: March 03, 2023

Mutation in the STXBP1 Gene Associated with Early Onset West Syndrome: A Case Report and Literature Review.

Mutation in the STXBP1 Gene Associated with Early Onset West Syndrome: A Case Report and Literature Review.

Journal: Pediatric reports

Published: August 05, 2022

Burden of seizures and comorbidities in patients with epilepsy: a survey based on the tertiary hospital-based Epilepsy Syndrome Registry in Japan.

Burden of seizures and comorbidities in patients with epilepsy: a survey based on the tertiary hospital-based Epilepsy Syndrome Registry in Japan.

Journal: Epileptic disorders : international epilepsy journal with videotape

Published: February 04, 2022

CUX2 deficiency causes facilitation of excitatory synaptic transmission onto hippocampus and increased seizure susceptibility to kainate.

CUX2 deficiency causes facilitation of excitatory synaptic transmission onto hippocampus and increased seizure susceptibility to kainate.

Journal: Scientific reports

Published: December 02, 2021

Current medico-psycho-social conditions of patients with West syndrome in Japan.

Current medico-psycho-social conditions of patients with West syndrome in Japan.

Journal: Epileptic disorders : international epilepsy journal with videotape

Published: July 16, 2021

The effectiveness of intravenous benzodiazepine for status epilepticus in Dravet syndrome.

The effectiveness of intravenous benzodiazepine for status epilepticus in Dravet syndrome.

Journal: Brain & development

Published: June 19, 2021

Showing 1-12 of 65

Last Updated: 09/26/2026